Phase I study protocol for ex-vivo lentiviral gene therapy for the inherited skin disease, Netherton Syndrome
Human Gene Therapy Clinical Development · 2013
DOI: 10.1089/hum.2013.195 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Human Gene Therapy Clinical Development, 2013. Verfasst von Wei-Li Di und 11 weiteren Autor:innen. Beteiligte Einrichtung: UCL Institute of Child Health, London, UK, London, United Kingdom ; w.di@ucl.ac.uk. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- UCL Institute of Child Health, London, UK, London, United Kingdom ; w.di@ucl.ac.uk.
Zitieren
APA
Di, W. L., Mellerio, J. E., Bernadis, C., Harper, J., Abdul-Wahab, A., Ghani, S., Martinez-Queipo, M., Hara, H., McNicol, A. M., McGrath, J., Thrasher, A. J., & Qasim, W. (2013). Phase I study protocol for ex-vivo lentiviral gene therapy for the inherited skin disease, Netherton Syndrome. Human Gene Therapy Clinical Development. https://doi.org/10.1089/hum.2013.195
Vancouver
Di WL, Mellerio JE, Bernadis C, Harper J, Abdul-Wahab A, Ghani S, et al. Phase I study protocol for ex-vivo lentiviral gene therapy for the inherited skin disease, Netherton Syndrome. Human Gene Therapy Clinical Development. 2013. doi:10.1089/hum.2013.195
BibTeX
@article{Di2013,
author = {Di, Wei-Li and Mellerio, Jemima E and Bernadis, Catina and Harper, John and Abdul-Wahab, Alya and Ghani, Sumera and Martinez-Queipo, Magdalena and Hara, Havinder and McNicol, Anne-Marie and McGrath, John and Thrasher, Adrian J and Qasim, Waseem},
title = {Phase I study protocol for ex-vivo lentiviral gene therapy for the inherited skin disease, Netherton Syndrome},
journal = {Human Gene Therapy Clinical Development},
year = {2013},
doi = {10.1089/hum.2013.195}
}
EUVIMED